💨 Abstract

Thousands of Brits may inadvertently invalidate their travel insurance policies by not disclosing their use of GLP-1 drugs like Mounjaro, Ozempic, and Wegovy. These drugs, often taken for weight loss or managing diabetes, must be declared as pre-existing conditions. Failure to do so can lead to denied claims and severe financial consequences, as insurers can refuse coverage even for unrelated issues. Experts advise declaring all medications and checking destination-specific regulations when traveling.

Courtesy: Jessica Lindsay